Warner Bros. Discovery, Inc.
Cyclic compound acting as PDE4 inhibitor
Last updated:
Abstract:
Provided are a phosphodiesterase-4 (PDE4) inhibitor and application thereof in preparation of a medication for treating a disease related to PDE4. Specifically disclosed is a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
22 Aug 2017
Issue date:
14 Jan 2020